HDAC9-IN-1

Product Overview

• Article Name: HDAC9-IN-1
• Biozol Catalog Number: MCE-HY-169259
• Supplier Catalog Number: HY-169259
• Alternative Catalog Number: MCE-HY-169259-25MG,MCE-HY-169259-100MG,MCE-HY-169259-50MG,MCE-HY-169259-5MG,MCE-HY-169259-10MG,MCE-HY-169259-10MMX1ML
• Manufacturer: MedchemExpress
• Category: Biochemikalien

Product Description

HDAC9-IN-1 is a selective class IIa HDAC inhibitor that binds to HDAC9 with an IC50 of 40 nM. HDAC9-IN-1 potently inhibits HDACs 4 and 7 while showing weak activity against HDAC6 (IC50 values: 180 nM (HDAC4), 190 nM (HDAC7), 970 nM (HDAC6)). HDAC9-IN-1 significantly inhibits several human cancer cells, induces apoptosis and DNA damage in human cancer cells, and modulates caspase-related proteins and p38 in human cancer cells. HDAC9-IN-1 can be used for the research of oral cancer, breast cancer, gastric cancer[1].

Product Properties

• Molecular Weight: 482.55
• Purity: 95.13
• Formula: C27H22N4O3S
• Target: Apoptosis,Caspase,DNA/RNA Synthesis,HDAC,p38 MAPK,Reactive Oxygen Species (ROS)

Application Notes

• Application Notes: MCE Product type: Reference compound